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ABSTRACT 
Objective: Indole derivatives were reported to a wide range of biological activities. Thus it was our aim to synthesize a series of 2-(2'/3'/4'/6'-
substituted phenyl) -1H-indoles using clayzic catalyst and screen for their in vitro anti-inflammatory, antioxidant and antimicrobial activities.  
Methods: Various substituted acetophenones were reacted with phenylhydrazine in the presence of modified clayzic catalyst and obtained 2-
(2'/3'/4'/6'-substituted phenyl)-1H-indoles in a one pot reaction. The cyclized compounds were characterized by FT-IR, NMR, UV-Vis and mass 
spectral analyses and screened for anti-inflammatory activity against cytokines tumor necrosis factor (TNF-α) and interleukin-6 (IL-6) by 
measuring cytokine production by performing sandwich ELISA model, antioxidant activity by DPPH assay method and antimicrobial activity by 
well-diffusion method. 
Results: An eco-friendly route with better yields for the synthesis of 2-(2'/3'/4'/6'-substituted phenyl)-1H-indoles in the presence of clayzic 
catalyst was achieved. The biological activity results suggested that compounds (2d, 2e and 2i) have excellent anti-inflammatory activity, 
compounds (2a-2d and 2j) possessing better antioxidant property and compounds (2b, 2i, 2k and 2m) have promising antibacterial and antifungal 
activities when compared to the standard drugs.  
Conclusion: Synthesis of 2-(2'/3'/4'/6'-substituted phenyl)-1H-indoles was successfully achieved in the presence of clayzic catalyst. Compounds 
bearing amino, methyl, methoxy, hydroxyl and fluoro groups have shown better anti-inflammatory, antioxidant and antimicrobial activities when 
compared to the other compounds and 1H-indole.  
Keywords: Fischer indole synthesis, 2-(2'/3'/4'/6'-substituted phenyl)-1H-indoles, Clayzic catalyst, In vitro anti-inflammatory activity, Antioxidant 
study, Antimicrobial activity. 
 
INTRODUCTION 
Generally, fused N-containing heterocyclic pharmacophore have a 
significant role in medicinal chemistry. Among them, indole nucleus 
occupies a unique position in heterocyclic chemistry due to its 
noticeable pharmacological properties and thus stands as an 
important scaffold in drug design. The most important anti-HIV 
drugs (Delavirdine, Atevirdine), anti-cancer drugs (Vincristine, 
Vinblastine) and the successful anti-inflammatory drug 
Indomethacin led to the exploration of various substituted indoles in 
order to develop better bioactive indoles. Furthermore, various 2-
substituted indoles are well known for their widespread biological 
properties such as anti-inflammatory [1]. GABAA receptor 
antagonists [2], antioxidant [3], antibacterial [4], antifungal [5] and 
COX-inhibitors [6]. 2-Phenylindole-3-carbaldehyde was reported as 
an effective scaffold against breast cancer cell lines by inhibiting the 
polymerization of tubulin to functional microtubules [7]. These 
results prompted us to study the biological activities of various 
substituted indoles in more detail.  
Inflammation is the body’s response to the harmful stimuli, damaged 
cells and pathogens to begin the healing process. Chronic 
inflammation can lead to several diseases such as cancers, 
rheumatoid arthritis, atherosclerosis, periodontitis, and hay fever 
[8]. Nonsteroidal anti-inflammatory drugs (NSAIDs) can inhibit COX-
2 enzyme and thereby inhibiting proliferation and inducing 
apoptosis of many malignant tumors [9, 10]. Studies have also 
demonstrated that NSAIDs can be effective in chemoprevention and 
treatment of many tumoral and cancer diseases [11, 12]. They also 
stand as an uncontrollable problem in the form of allergies and 
gastrointestinal risks. Thus, there is a need to develop new NSAIDs 
in order to avoid the side effects, to improve safety and tolerability. 
Antibiotic resistance is one of the serious problems in contemporary 
medicine and multidrug resistant microbes are thus becoming a 
serious threat to human life. Literature revealed that bacterial 
infection is strongly related to inflammation [13], the development 
of antibacterial agents having anti-inflammatory property is 
necessary to combat against these threats. In addition, antioxidants 
protect cells from reactive oxygen species, which lead to cancer, 
aging, atherosclerosis, ischemic injury, inflammation, and 
neurodegenerative diseases [14]. Hence, it was planned to 
synthesize the targets possessing various biological activities to 
inhibit the risks.  
Although various catalytic systems for Fischer indole synthesis have 
been well studied in the literature, there is still continuing an effort 
to find the promoters to enhance the reaction rate under mild 
reaction conditions. The reported methods are time consuming, 
needs strong acid, high temperature and less purity of the desired 
products. The use of the moderate-strength Lewis acid, zinc chloride 
catalyst results in less waste and easy separation by water wash, it is 
widely used for Fischer indole cyclization. Nowadays, the use of 
reagents or catalysts on solid supports has experienced remarkable 
attention. Zinc chloride exchanged clay known as “clayzic” has been 
efficiently used as an environmentally friendly catalyst “Envirocat” 
in various Lewis acid catalyzed reactions even at room temperature 
[15-17]. Based on these considerations, we reported here the clayzic 
catalyzed synthesis of 2-(2’/3’/4’/6’-substituted phenyl)-1H-indoles 
and their in vitro anti-inflammatory, antioxidant, antibacterial and 
antifungal activities.  
MATERIALS AND METHODS 
Chemicals 
All acetophenones and montmorillonite K-10 clay catalyst were 
purchased from Sigma-Aldrich Chemical & Co., and used without 
purification. The solvent methanol purchased from Thomas Baker 
was used. Phenylhydrazine hydrochloride and zinc chloride used 
were purchased from SD fine chemicals limited. Nutrient broth for 
bacterial and fungal studies was purchased from Hi-Media.  
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Instrumentation and analytical procedures 
The melting point of all compounds was determined by open 
capillary melting point apparatus and uncorrected. FT-IR spectra 
were recorded in the Shimadzu IR Affinity-1 CE model with 
resolution 4 using KBr technique. UV spectra were recorded in a 
Jasco UV-Visible NIR spectrometer of model V670. The XRD patters 
were recorded in Bruker D8 Advance with CuKα radiation (Kαλ = 
1.5406Å). The percentage conversion and molecular weight of the 
products were done by GC-MS chromatogram (Perkin Elmer system 
of GC model Clarus 680 and MS model Clarus 600 (EI)) using helium 
as a carrier gas. 1H NMR and 13C NMR spectra were recorded on 
Bruker 400MHz FT-NMR uses CDCl3/DMSO-d6 as a solvent and 
tetramethylsilane as internal standard. Chemical shifts are 
expressed in PPM. 
Preparation of the clayzic catalyst 
The catalyst was prepared by impregnating 1g K-10 clay (surface: 
220-270 m2/g; bulk density: 300-370 g/l) with 1g of powdered 
anhydrous zinc chloride in tetrahydrofuran (THF). The clayzic 
suspension was centrifuged, dried at 80oC for 2h and grounded into 
a fine powder. Then, the catalyst was dried and stored in a moisture-
free environment. Before using for the reaction, the catalyst was 
heated to 100oC to remove the absorbed moisture. The XRD pattern 
in the fig. 1 clearly confirms the presence of the zinc on the active 
sites of the K-10 clay catalyst.  
General procedure for the synthesis of 2-(2'/3'/4'/6'-
substituted phenyl)-1H-indoles (2a-m) 
Acetophenone (1a) (0.5 mmol) and phenylhydrazine (0.5 mmol) 
were dissolved in 10 ml methanol. The mixture was then warmed on 
the water bath and glacial acetic acid was added till the solution 
became clear. Clayzic catalyst (200 mg) was added to the above 
reaction mixture and refluxed. The reaction was monitored by TLC 
using petroleum ether and ethyl acetate (4:1). Upon completion of 
the reaction in 20 min, the reaction mixture was cooled to room 
temperature, filtered and poured the filtrate into the crushed ice. 
The solid K-10 clay catalyst that remained in the filter paper was 
thoroughly washed with a brine solution, dried and reused.  
The product formed was then extracted with dichloromethane and 
roto-evaporated to get the crude product (2a). The crude product 
was purified by column chromatography using petroleum ether and 
ethyl acetate (90:10), yield (92%). The other substituted 
acetophenones (1b-m) were also subjected to the same procedure 
by utilizing 200-400 mg of the modified clayzic catalyst and obtained 
the cyclized compounds (2b-m) of about 60-90% yield. We observed 
better yield of the desired products in less reaction time when 
compared to the reported methods. 
Characterization 
2-Phenylindole (2a) 
White solid; Yield: 92%; Melting point (oC): 192 (Lit.: 184-185 [20]); 
IR(KBr) Vmax (cm-1): 3442.87 (-NH); 1H NMR (400MHz, CDCl3)δ: 
6.835 (s, 1HArom), 7.106-7.181 (dd, 4HArom), 7.200 (t, 1HArom), 7.312-
7.683 (m, 4HArom) 8.348 (s, 1H,-NH); 13C NMR (100MHz, CDCl3)δ: 
100.01, 110.89, 120.29, 120.69, 122.38, 125.17, 127.74, 129.05, 
129.28, 136.82, 137.89; GC-MS: 115, 165, 193.2511 (100%) (M+); 
UV/vis λmax (MeOH): 235, 310 nm. 
2-(4'-Aminophenyl) indole (2b) 
Brown solid; Yield: 92%; m. p. (oC): 207 (Lit: 201-202 [21]); IR(KBr) 
Vmax (cm-1): 3527.80 (-NH); 3257.77(-NH2); 1H NMR (400MHz, 
DMSO)δ: 5.286 (s, 2H,-NH2), 6.583-7.536 (d, 4HArom), 6.728 (s, 
1HArom), 7.202 (s, 4HArom), 8.946 (s, 1H,-NH); 13C NMR (100MHz, 
DMSO)δ: 112.48, 113.42, 118.03, 126.21, 128.75, 130.53, 141.92, 
146.62; GC-MS: 117, 152, 192, 208.2850 (100%) (M+); UV/vis λmax 
(MeOH): 210, 325 nm. 
2-(4'-Chlorophenyl) indole (2c) 
White solid; Yield: 86%; m. p. (oC): 193 (Lit.: 193-195 [20]); IR(KBr) 
Vmax (cm-1): 3442.94 (-NH); 1H NMR (400MHz, CDCl3)δ: 6.814 (s, 
1HArom), 7.117-7.912 (m, 8HArom), 8.287 (s, 1H,-NH); 13C NMR 
(100MHz, CDCl3)δ: 100.62, 111.08, 120.61, 120.90, 122.83, 126.46, 
129.31, 129.37, 131.04, 133.59, 136.82, 137.05; GC-MS: 114, 165, 
191, 227.1465 (100%) (M+), 229; UV/vis λmax (MeOH): 245, 315 
nm. 
2-(4'-Methylphenyl) indole (2d) 
White solid; Yield: 70%; m. p. (oC): 219 (Lit.: 210-212 [20]); IR(KBr) 
Vmax (cm-1): 3433.29 (-NH); 1H NMR (400MHz, CDCl3)δ: 2.208(s, 3H,-
CH3), 6.844-6.880 (t, 1HArom), 7.165-7.183 (d, 4HArom), 7.238-7.293 (t, 
1HArom),7.289 (s, 1HArom), 7.673-7.693(d, 2HArom); 13C NMR (100MHz, 
CDCl3)δ: 26.85, 122.39, 122.99, 126.43, 126.88, 128.44, 129.07, 
129.24, 130.39, 131.13, 145.91, 152.35; GC-MS: 115, 178, 191, 
207.1427 (100%) (M+); UV/vis λmax (MeOH): 205, 240, 345 nm. 
2-(4'-Methoxyphenyl) indole (2e) 
White flakes; Yield: 65%; m. p. (oC): 226 (Lit.: 226-227 [22]); IR(KBr) 
Vmax (cm-1): 3429.43(-NH); 1H NMR (400MHz, CDCl3)δ: 3.833(s, 3H,-
OCH3), 6.842-6.904(t, 2HArom), 6.921 (s, 1HArom), 7.157-7.293 (d, 
4HArom),7.729-7.750(d, 2HArom); 13C NMR (100MHz, CDCl3)δ: 55.35, 
113.17, 113.70, 113.74, 119.97, 126.88, 129.24, 130.62, 145.46, 
159.67; GC-MS: 117, 131, 207, 224.2504 (M+); UV/vis λmax (MeOH): 
240, 295, 325 nm. 
2-(3'-Nitrophenyl) indole (2f) 
Pale yellow crystals; Yield: 85%; m. p. (oC): 176 (Lit.: 172 [23]); 
IR(KBr) Vmax (cm-1): 3425.58 (-NH); 1H NMR (400MHz, CDCl3)δ: 
7.031 (s, 1HArom), 7.150-7.295(t, 2HArom), 7.434-8.320 (d, 6HArom), 
8.444(s, 1H,-NH); 13C NMR (100MHz, CDCl3)δ: 103.62, 111.40, 
121.13, 121.52, 124.14, 124.73, 125.30, 129.09, 138.55, 196.45; LC-
MS: 116, 238.2014 (100%) (M+); UV/vis λmax (MeOH): 235, 265, 
385 nm. 
2-(4'-Nitrophenyl) indole (2g) 
Yellow crystals; Yield: 90%; m. p. (oC): 178-180 (Lit.: 188-190 [20]); 
IR(KBr) Vmax (cm-1): 3429.43 (-NH); 1H NMR (400MHz, CDCl3)δ: 
7.032(s, 1HArom), 7.150-7.296 (t, 2HArom), 7.435-8.322 (d, 6HArom), 
8.453(s, 1H,-NH); 13C NMR (100MHz, CDCl3)δ: 103.48, 111.27, 
120.99, 121.39, 123.90, 124.00, 124.59, 125.17, 128.96, 196.35; LC-
MS: 117, 174, 238.10 (100%) (M+); UV/vis λmax (MeOH): 230, 265, 
390 nm. 
2-(2', 6'-Dimethylphenyl) indole (2h) 
White solid; Yield: 61%; m. p. (oC): 184-170; IR(KBr) Vmax (cm-1): 
3414.00(-NH); 1H NMR (400MHz, DMSO)δ: 2.434-2.497(s, 6H,-CH3), 
6.796-6.816 (d, 2HArom), 6.927-6.971 (t, 1HArom), 7.069 (s, 1HArom), 
7.159-7.271 (t, 2HArom), 7.344-7.379(d, 2HArom), 7.512 (s, 1H,-NH); 
LC-MS: 117, 191, 206, 221.80 (100) (M+); UV/vis λmax (MeOH): 225, 
275, 305 nm.  
2-(3', 4'-Dimethoxyphenyl) indole (2i) 
White flakes; Yield: 62%; m. p. (oC): 178-192 (Lit.: 190 [24]); IR(KBr) 
Vmax (cm-1): 3415.93(-NH); 1H NMR (400MHz, CDCl3)δ: 3.871-
3.903(s, 6H,-OCH3), 6.157-6.293 (d, 2HArom), 6.521(s, 1HArom), 
7.043(s, 1HArom), 7.138-7.182(t, 2HArom),7.729-7.750(d, 2HArom); GC-
MS: 149(100%), 253.2663 (M+); UV/vis λmax (MeOH): 210, 247, 
277, 315 nm. 
2-(2'-Hydroxyphenyl) indole (2j) 
Greenish yellow crystals; Yield: 82%; m. p. (oC): 160-162 (Lit.: 184-
185 [26]); 1H NMR (400MHz, CDCl3)δ: 5.585 (s,-OH), 6.868 (s, 
1HArom), 6.889-6.923(d, 2HArom), 7.007-7.030(dd, 1HArom), 7.169-
7.206(t, 1HArom), 7.348-7.352(d, 1HArom), 7.371-7.410(t, 
2HArom),7.616-7.640(dd, 1HArom), 14.651(s,-NH); 13C NMR (100MHz, 
CDCl3)δ: 115.12, 118.14, 118.28, 119.77, 121.31, 124.82, 128.93, 
129.09, 133.07, 136.50, 147.03, 162.01, 171.18; GC-MS: 120, 167, 
196 (100%), 211 (M+2); UV/vis λmax (MeOH): 221, 257, 321 nm. 
2-(4'-Fluorophenyl) indole (2k) 
Off white solid; Yield: 78%; m. p. (oC): 188-190 (Lit.: 188 [25]); 1H 
NMR (400MHz, DMSO)δ: 6.710-6.729 (d, 4HArom), 7.123-7.141 (d, 
4HArom), 7.992(s, 1HArom); GC-MS: 151, 170, 199 (100%), 213.2732 
(M+2); UV/vis λmax (MeOH): 203, 232, 286 nm. 
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2-(2'-Bromophenyl) indole (2l) 
Pale yellow solid; Yield: 62%; m. p. (oC): 70-72 (75-77 [27]); 1H NMR 
(400MHz, CDCl3)δ: 6.93 (s, 1HArom), 7.415-7.891 (m, 8HArom), 11.37 (s, 
1H,-NH); GC-MS: 117, 195, 272 (100%), 274.1039 (98%) (M+2); 
UV/vis λmax (MeOH): 222, 281 nm. 
2-(4'-Bromophenyl) indole (2m) 
Off white solid; yield: 80%; m. p. (oC): 208-210; 1H NMR (400MHz, 
CDCl3)δ: 6.834 (s, 1HArom), 7.217-7.992 (m, 8HArom), 8.87 (s, 1H,-NH); 
13C NMR (100MHz, CDCl3)δ: 100.06, 111.18, 120.42, 120.78, 122.18, 
126.26, 129.11, 129.30, 131.64, 133.69; GC-MS: 116, 178, 272 
(100%) (M+), 274.2528 (98%) (M+2); UV/vis λmax (MeOH): 221, 
285, 318 nm. 
In vitro anti-inflammatory assay 
Inflammation IL-6 and TNF-α screening 
The human monocytic cell line THP-1 (ATCC, Manassas, VA) was 
maintained in RPMI-1640 (Bioconcept) supplemented with 10 % 
FBS (GIBCO). Prior to LPS-stimulation, 25,000 cells per well were 
cultured for 24 h in the presence of 10 ng/ml of phorbol 12-
myristate 13-acetate (PMA, Sigma-Aldrich) to enhance their 
response to activation stimuli. These cells were then stimulated with 
1 μg/ml LPS (Sigma-Aldrich) for 24 h in the presence or absence of 
10 μg/ml extract at 0.5% DMSO concentration. At the end of 24 h, 
the cell supernatant was used for cytokine measurements, and the 
cells used for determining the toxic effects of the compounds by 
exposure to CCK-8 reagent from Do Jindo. For all experiments, the 
THP-1 monocytes were used only up to passage # 25 and were 
utilized within 2 mo post revival of a new vial. 
Cytokine determination 
The monocytes were maintained in RPMI-1640 supplemented with 
10% FBS, and cytokine expression in the presence or absence of the 
compound was determined. The levels of cytokines generated were 
assessed by ELISA from BD Biosciences having a sensitivity 
threshold of 4.6 pg/ml for IL-6 and 7.8 pg/ml for TNF-α. 
Simultaneously, assays were performed to determine the effect of 
the compound on cellular viability using CCK-8, a dehydrogenase 
activity measurement kit. 
In vitro antimicrobial assay 
All the synthesized 2-(2'/3'/4'/6'-substituted phenyl)-1H-indoles 
were screened for their in vitro antibacterial activity against 
Escherichia coli, Pseudomonas aeruginosa, Bacillus subtilis and 
Staphylococcus aureus and antifungal activity against Candida 
albican, Aspergillus fumigates and Aspergillus niger according to agar 
well diffusion method [18]. The inoculated suspensions of organisms 
in sterile distilled water were uniformly distributed to a density of 5 
mm with a glass spreader onto the sterilized petri dishes (25 ml) 
and allowed to solidify for at least 3 min but no longer than 15 min 
before making wells. A hollow tube of 5 mm diameter was heated 
and pressed on above the inoculated agar plates and was removed 
immediately. Similarly, five wells were made on each plate. Sample 
stock solutions were prepared to about 1 mg/ml by using DMSO as a 
solvent and which were serially added (50, 100, 150 and 200 μl) to 
each well with the help of a micropipette. The plates were incubated 
for 18-24 h at 37°C in an incubator. Amoxicillin and Clotrimazole 
were used as the positive control and DMSO as blank. The plates 
were read only if the lawn of growth was confluent or nearly 
confluent. The diameter of the inhibition zone was measured to the 
nearest whole millimeter by holding the measuring device. The 
obtained results were represented in table 1 revealed that all the 
compounds possessing moderate to good antibacterial and 
antifungal activities.  
Minimum inhibitory concentration (MIC) of the compounds 2b, 2i 
and 2k against E. coli & Pseudomonas aeruginosa (Gram negative 
Bacteria) and compounds 2i and 2m against Candida albicans and 
Aspergillus niger were determined by the Broth Micro dilution 
method. The stock solutions of the compounds and the drugs were 
prepared by using DMSO, which had no effect on the organisms in 
the preliminary studies. Various concentrations (100, 50, 25, 12.5, 
6.25, 3.125, 1.56 µg/ml) of the compounds and the drugs were 
prepared. The lowest concentration that resists the micro-organisms 
growth was noted as the MIC and represented the results in table 2.  
DPPH radical scavenging assay 
The radical scavenging activity of synthesized compounds against 
2, 2-diphenyl-2-picyrl hydrazyl hydrate (DPPH) was determined 
by using Brand-Williams et al. (1995) method [19]. Ascorbic acid 
was used as a standard. The reaction mixture contains 0.4 ml of 1 
mmol freshly prepared DPPH, different volume (80, 160, 240, 320 
and 400 µl) of 1 mg/ml solution of the compounds and the 
required volume of ethanol to make the whole mixture to 4 ml. A 
blank was prepared without the addition of the samples. After 
additions, the reaction mixtures were kept in the dark at room 
temperature for 30 min. The change in color (from violet to 
yellow) was observed, and their absorbance was measured at 517 
nm by using UV-Vis spectrophotometer. Lower the absorbance of 
the mixture indicates the higher radical scavenging activity. The 
experiment was done in triplicate to find the mean and standard 
deviation. % Radical scavenging activity was calculated by using 
the following equation:  
%	Inhibition	 = 	AB− AS
AB
 	X	100 
Where, AB–Absorbance of blank sample (t = 0 min); AS–Absorbance 
of test samples (t = 30 min).  
RESULTS AND DISCUSSION 
Chemistry  
As we aim to achieve the targets in mild reaction conditions with 
higher yields and in less reaction time, the reaction has been carried 
out thermally in the presence of a modified clayzic catalyst as shown 
in Scheme 1. The reaction was completed much earlier and also the 
yields were better when compared to the use of other catalysts. It is 
expected that the Lewis acidity of the cations on the edge sites on 
the K-10 clay catalyst was accelerated by the addition of the zinc 
chloride. It has also been observed that the rate of the reaction 
depends on the nature of the substituents in the acetophenones and 
the solvent used.  
 
Scheme 1: Clayzic catalyzed Fischer indole synthesis from 
various substituted acetophenones 
 
 
Fig. 1: XRD patterns of Clay, Clayzic and used clay catalysts 
The chloro, methyl, nitro, bromo and fluoro substituted 
acetophenones underwent cyclization in very short time 
comparatively and the polar solvent methanol favored the reaction. 
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The zinc salt was easily washed off with water and the 
montmorillonite K-10 clay catalyst was finally recovered from the 
reaction mixture by filtration, washed with brine solution, dried and 
reused. The characteristics of the clay catalyst, depending on its 
active sites were also evidenced by their XRD results in fig. 1. The 
activity of the clay catalyst was effective up to 3-5 times. The 
successful results prompted us to go for one pot synthesis of the 
series of 2-(2'/3'/4'/6'-substituted phenyl)-1H-indoles in the 
methanol medium by thermal method. 
Biological screening 
Antimicrobial study 
Antibacterial and antifungal screening results of the compounds (2a-
2m) revealed their slight to moderate activity against chosen 
bacterial and fungal strains ranged from 60% of the standards. All 
the compounds have shown better activity against Pseudomonas 
aeruginosa and low activity against Aspergillus fumigates. In 
addition, it was found that the activities of the substituted indoles 
were better than the unsubstituted 1H-indole. Indoles with 4'-
aminophenyl, 2', 6'-dimethylphenyl, 4'-fluorophenyl and 2'-
bromophenyl at its second position possessing better activity than 
the other substituted indoles.  
Compounds (2b, 2i, 2k and 2m) were screened for MIC studies. 
Compounds (2i and 2k) were shown better antibacterial activity 
with MIC of 9.37µg/ml against E. coli and 9.37µg/ml against 
Pseudomonas aeruginosa. Compound (2i) showed better antifungal 
activity with MIC of 9.37μg/ml against Candida albicans and 9.37 
μg/ml against Aspergillus niger. Antimicrobial and MIC results have 
been clearly tabulated in table 1 & table 2. 
Anti-inflammatory study  
The anti-inflammatory activity of the synthesized compounds at 
different concentration (10, 30, 50, 80, 100 μM) was evaluated and 
listed the results for 50 μM concentration along with their IC50 value 
in table 3. The anti-inflammatory results showed that compounds 
(2d, 2e and 2i) bearing 4'-methylphenyl, 4'-methoxyphenyl and 3', 
4'-dimethoxyphenyl at the 2-position of the indole shown 
comparable inhibition with the standard. Also, the compound (2f) 
bearing nitro substituent at the meta position of the phenyl ring 
shown less inhibition compared to the same substituent at the para 
position as in the compound (2g).  
The electron releasing substituent’s on the phenyl ring of the 
compounds (2b and 2h) have shown less activity. No toxicity was 
observed upto 50 μM concentration of all the compounds as shown 
in table 3. Thus, the overall study implies that the 2-(2'/3'/4'/6'-
substituted phenyl)-1H-indoles possessing significant anti-
inflammatory activity along with antibacterial and antifungal 
activities. 
  
Table 1: Antimicrobial results of 2-(2'/3'/4'/6'-substituted phenyl)-1H-indoles (2a-m) 
Compo
unds 
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Table 2: MIC results of compounds (2b, 2i, 2k and 2m) shown better zone of inhibition 
Bacteria:   Against escherichia coli Against pseudomonas aeruginosa 
Samples (μg/ml)  100 50 25 12.5 6.25 3.125 1.56 MIC  100 50 25 12.5 6.25 3.125 1.56 MIC  
2b S S S R R R R 18.7+3.15 S S S R R R R 18.7+3.15 
2i S S S S R R R 9.37+1.56 S S S S R R R 9.37+1.56 
2k S S S S R R R 9.37+1.56 S S S S R R R 9.37+1.56 
Amoxicillin  S S S S S S R 2.34+0.39 S S S S S S R 2.34+0.39 
Fungi:  Against Candida albicans Against Aspergillus niger 
2i S S S S R R R 9.37+1.56 S S S S R R R 9.37+1.56 
2m S S S S R R R 9.37+1.56 S S S R R R R 18.7+3.15 
Clotrimazole S S S S S R R 4.68+0.78 S S S S R R R 9.37+1.56 
R-resistant; S-sensitive; MIC: Mean+SD in μg/ml 
 
Table 3: Anti-inflammatory results of 2-(2'/3'/4'/6'-substituted phenyl)-1H-indoles (2a-m) 
Compounds Anti-inflammatory results % Toxicity  
(Concentration in μM) Concentration in μM % inhibition (Mean+SD) IC50 in μM 
TNF-α IL6 TNF-α IL6 
2a 50 48.76+1.26 84.97+0.65 50 30 0 (200) 
2b 50 42.24+0.81 84.95+0.92 55 20 4 (200) 
2c 50 49.38+1.26 86.25+1.04 50 20 11 (100) 
2d 50 77.54+0.25 94.87+0.94 25 10 7 (130) 
2e 50 70.39+0.48 92.54+0.17 30 10 20 (130) 
2f 50 51.09+0.90 90.40+0.31 50 10 35 (80) 
2g 50 11.65+1.45 92.28+0.95 120 20 5 (80) 
2h 50 2.47+0.12 71.27+0.68 120 30 3 (100) 
2i 50 68.33+1.03 97.31+0.87 30 10 4 (130) 
2j 50 48.21+1.25 86.26+1.11 50 30 17 (80) 
2k 50 52.01+0.28 79.57+0.17 50 30 12 (100) 
2l 50 50.97+1.01 93.23+0.65 50 10 10 (80) 
2m 50 49.70+0.72 63.17+0.22 50 30 12 (100) 
Indole 50 47.13+0.85 59.48+0.70 50 30 0 (200) 
Standard drug 10 60.08+0.28 63.65+0.21 <10 <10 0(200) 
 
Antioxidant study 
The DPPH radical scavenging method is extensively used to evaluate 
the antioxidant activity in shorter time duration. DPPH, which is a 
stable free radical, can accept hydrogen radical or an electron shows 
a strong absorption band at 517 nm. This assay measures the 
electron donor capability of the compounds.  
The color of DPPH changes from violet to yellow on reduction by 
the compounds. The antioxidant results are tabulated in table 4. 
Results suggested that compounds (2a, 2c, 2d, 2k and 2m) 
possessing better radical scavenging activity (85, 88, 71, 86 and 
76%) at 100 μg/ml and the remaining compounds shown 
moderate. The IC50 values of all the screened compounds have 
been calculated and tabulated. 
 
Table 4: DPPH radical scavenging activity of compounds (2a-2m) 
Compounds % Radical scavenging activity (Mean+SD) (μg/ml) 
Concentration (μg/ml) 
20 40 60 80 100 IC50 
Ascorbic acid 52.30+0.01 88.27+0.04 90.99+0.03 94.22+0.08 100.09 <20 
2a  9.18+0.03 32.40+0.04 56.21+0.08 82.40+0.11 85.27+0.13 55+0.06 
2b  1.53+0.01 34.95+0.05 55.19+0.02 58.78+0.01 61.28+0.03 55+0.04 
2c  25.17+0.03 31.72+0.11 56.38+0.05 58.67+0.03 88.20+0.13 55+0.08 
2d  17.18+0.05 31.89+0.09 58.84+0.05 69.56+0.02 71.51+0.09 46+0.07 
2e  10.03+0.03 17.18+0.05 23.81+0.02 55.19+0.03 68.11+0.08 77+0.03 
2f  0.51+0.04 16.67+0.07 33.76+0.01 36.99+0.05 53.40+0.08 96+0.03 
2g  5.10+0.01 26.87+0.11 34.44+0.04 51.28+0.04 56.63+0.10 79+0.08 
2h  9.01+0.01 43.03+0.12 49.23+0.01 63.01+0.04 70.32+0.11 61+0.03 
2i  7.99+0.04 18.88+0.01 22.28+0.04 48.91+0.03 49.89+0.12 100+0.03 
2j 6.89+0.04 15.22+0.03 55.70+0.03 77.64+0.01 86.31+0.11 57+0.03 
2k  7.91+0.02 11.82+0.02 25.43+0.11 37.33+0.03 43.37+0.09 >100 
2l  1.45+0.01 11.05+0.06 30.19+0.05 33.42+0.02 52.47+0.10 98+0.03 
2m  3.32+0.01 9.44+0.05 24.49+0.03 55.95+0.02 76.92+0.10 76+0.03 
 
CONCLUSION 
We have successfully achieved the synthesis of 2-(2'/3'/4'/6'-
substituted phenyl)-1H-indoles in the presence of clayzic catalyst 
and screened their antimicrobial, anti-inflammatory and antioxidant 
activities. All compounds have shown moderate to good activity. 
Among them, 2-(4’-methylphenyl) indole (2d) showed better 
inhibitory activity against IL-6 (81%) when compared to the 
standard drug Dexamethasone (63%). All compounds were tested 
for toxicity and found safety equivalent to the standards. 2-(4'-
Aminophenyl) indole (2b) and 2-(4'-fluorophenyl) indole (2k) were 
identified as good antibacterial agents against Pseudomonas 
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aeruginosa and Escherichia coli respectively, and compound (2i) was 
identified as a good antifungal agent against Aspergillus niger and 
Candida albicans. All the compounds were shown good to better 
antioxidant property. Thus, further pharmacological and 
phytochemical analyses are required to develop new bioactive 
molecules.  
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